Evaluation of two line probe assays for rapid detection of mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB mycobacteria in HIV-infected individuals with suspected TB

Journal of Clinical Microbiology

Volumn 52, Issue 4, 2014, Pages 1052-1059

  Luetkemeyer, Anne F ^a   Kendall, Michelle A ^b   Wu, Xingye ^b   Lourenço, Maria Cristina ^c   Jentsch, Ute ^d   Swindells, Susan ^e   Qasba, Sarojini S ^f   Sanchez, Jorge ^g   Havlir, Diane V ^a   Grinsztejn, Beatriz ^c   Sanne, Ian M ^d,h   Firnhaber, Cynthia ^d,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c Funda??o Oswaldo Cruz   (Brazil)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f Montgomery County Planning Department   (United States)

^g ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^h RIGHT TO CARE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LINE PROBE ASSAY; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AMERICA; SPUTUM SMEAR; TUBERCULOSIS; CLASSIFICATION; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PROCEDURES; SPUTUM;

ADULT; AFRICA, SOUTHERN; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SENSITIVITY AND SPECIFICITY; SOUTH AMERICA; SPUTUM; TUBERCULOSIS;

EID: 84897131697     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02639-13     Document Type: Article

References (36)

1. Kang'ombe CT, Harries AD, Ito K, Clark T, Nyirenda TE, Aldis W, Nunn PP, Semba RD, Salaniponi FM. 2004. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int. J. Tuberc. Lung. Dis. 8:829-836. (Pubitemid 38937599)
2. Getahun H, Harrington M, O'Brien R, Nunn P. 2007. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369:2042-2049. http://dx.doi.org/10.1016/S0140-6736(07)60284-0. (Pubitemid 46908825)
3. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. 2010. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843. http://dx.doi.org/10.1016/S0140-6736(10)60410-2.
4. World Health Organization. 2008. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR0-TB). World Health Organization, Geneva, Switzerland.
5. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. 2008. Rapid Molecular screening for MDR TB in a high volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792. http://dx.doi.org/10. 1164/rccm.200709-1436OC. (Pubitemid 351490566)
6. Neonakis IK, Gitti Z, Petinaki E, Maraki S, Spandidos DA. 2007. Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates. Eur. J. Clin. Microbiol. Infect. Dis. 26:151-152. http://dx.doi.org/10.1007/s10096-007-0255-y. (Pubitemid 46215307)
7. Dorman SE, Chihota VN, Lewis JJ, van der Meulen M, Mathema B, Beylis N, Fielding KL, Grant AD, Churchyard GJ. 2012. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J. Clin. Microbiol. 50:1189-1194. http://dx.doi.org/10. 1128/JCM.05723-11.
8. McCarthy KD, Metchock B, Kanphukiew A, Monkongdee P, Sinthuwattanawibool C, Tasaneeyapan T, Rienthong S, Ngamlert K, Srisuwanvilai LO, Varma JK. 2008. Monitoring the performance of mycobacteriology laboratories: a proposal for standardized indicators. Int. J. Tuberc. Lung. Dis. 12:1015-1020.
9. Lan R, Yang C, Lan L, Ou J, Qiao K, Liu F, Gao Q. 2011. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. Int. J. Tuberc. Lung. Dis. 15:1669-1675. http://dx.doi.org/10.5588/ijtld.11.0036.
10. Marras TK, Daley CL. 2004. A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection. J. Acquir. Immune. Defic. Syndr. 36:883-889. http://dx.doi.org/10.1097/00126334- 200408010-00001. (Pubitemid 38944083)
11. Karakousis PC, Moore RD, Chaisson RE. 2004. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect. Dis. 4:557-565. http://dx.doi.org/10.1016/S1473-3099(04) 01130-2. (Pubitemid 39141797)
12. Bicmen C, Gunduz AT, Coskun M, Senol G, Cirak AK, Ozsoz A. 2011. Molecular detection and identification of Mycobacterium tuberculosis complex and four clinically important nontuberculous mycobacterial species in smear-negative clinical samples by the genotype mycobacteria direct test. J. Clin. Microbiol. 49:2874-2878. http://dx.doi.org/10.1128/JCM.00612-11.
13. Kent P, Kubica G. 1985. Public health mycobacteriology: a guide for level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
14. Rieder HL, Van Deun A, Kam KM, Jae Kim S, Chonde TM, Trebucq A, Urbanczik R. 2007. Priorities for tuberculosis bacteriology services in low-income countries, 2nd ed. International Union Against Tuberculosis and Lung Disease, Paris, France.
15. BD. 2002. MGIT package insert. Becton, Dickinson and Company, Sparks, MD. http://www.bd.com/ds/technicalCenter/inserts/8809501JAA(01).pdf#page= 1&view=Fit.
16. BD. 2010. MGIT SIRE package insert. Becton, Dickinson and Company, Sparks, MD. http://www.bd.com/ds/technicalCenter/inserts/8008200(201010). pdf#page=1&view=Fit.
17. Ling DI, Zwerling AA, Pai M. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174. http://dx.doi.org/10.1183/09031936.00061808.
18. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. 2013. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1:CD009593. CD009593.
19. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015. http://dx.doi.org/10.1056/NEJMoa0907847.
20. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377:1495-1505. http://dx.doi.org/10.1016/S0140-6736(11)60438-8.
21. Barnard M, Gey van Pittius NC, van Helden PD, Bosman M, Coetzee G, Warren RM. 2012. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J. Clin. Microbiol. 50:3712-3716. http://dx.doi.org/10.1128/JCM.01958-12.
22. Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N. 2012. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J. Clin. Microbiol. 50:1264-1269. http://dx.doi.org/10.1128/JCM.05903-11.
23. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, Pistorius C, Krause R, Bogoshi M, Churchyard G, Venter A, Allen J, Palomino JC, De Marez T, van Heeswijk RP, Lounis N, Meyvisch P, Verbeeck J, Parys W, de Beule K, Andries K, Mc Neeley DF. 2009. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N. Engl. J. Med. 360:2397-2405. http://dx.doi.org/10.1056/NEJMoa0808427.
24. Bang D, Andersen PH, Andersen AB, Thomsen VO. 2010. Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome. J. Infect. 60:452-457. http://dx.doi.org/10.1016/j.jinf.2010.03.017.
25. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P. 2009. Clinical characteristics and treatment outcomes of patients with isoniazidmonoresistant tuberculosis. Clin. Infect. Dis. 48:179-185. http://dx.doi.org/10.1086/595689.
26. Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, Vernon A, Lienhardt C. 2009. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 6:e1000150. http://dx.doi.org/10.1371/ journal.pmed.1000150.
27. Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB. 2011. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin. Infect. Dis. 53:369-372. http://dx.doi.org/ 10.1093/cid/cir406.
28. Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. 2012. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. Int. J. Tuberc. Lung. Dis. 16:203-205. http://dx.doi.org/10.5588/ ijtld.11.0445.
29. Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martin-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP. 2012. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int. J. Tuberc. Lung. Dis. 16:355-357. http://dx.doi.org/10.5588/ijtld.11.0542.
30. Jun HJ, Jeon K, Um SW, Kwon OJ, Lee NY, Koh WJ. 2009. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. Respir. Med. 103:1936-1940. http://dx.doi.org/10.1016/j.rmed.2009.05.025.
31. Pokam BT, Asuquo AE. 2012. Acid-fast bacilli other than mycobacteria in tuberculosis patients receiving directly observed therapy short course in cross river state, Nigeria. Tuberc. Res. Treat. 2012:301056. http://dx.doi.org/10. 1155/2012/301056.
32. McCarthy KD, Cain KP, Winthrop KL, Udomsantisuk N, Lan NT, Sar B, Kimerling ME, Kanara N, Lynen L, Monkongdee P, Tasaneeyapan T, Varma JK. 2012. Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am. J. Respir. Crit. Care Med. 185:981-988. http://dx.doi.org/10.1164/rccm.201107- 1327OC.
33. Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, Muirhead D, Churchyard GJ. 2010. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int. J. Tuberc. Lung. Dis. 14:1024-1031.
34. Dowdy DW, Lourenco MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE. 2008. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One 3:e4057. http://dx.doi.org/10.1371/journal.pone.0004057.
35. Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Nguyen HD, Nguyen TN, Nguyen TB, Teeratakulpisarn N, Udomsantisuk N, Heilig C, Varma JK. 2009. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am. J. Respir. Crit. Care Med. 180:903-908. http://dx.doi.org/10.1164/rccm.200905-0692OC.
36. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. 2010. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int. J. Tuberc. Lung Dis. 14:1295-1302.